Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesMalignant neoplasms of lip, oral cavity and pharynxICD-10-CM c13-malignant-neoplasm-of-hypopharynx
    Ask Trek AI about this page

    ICD-10-CM Code For Malignant Neoplasm Of Hypopharynx: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group C13 includes malignant neoplasms arising in the hypopharynx, such as cancers of the pyriform sinus, postcricoid area, and posterior pharyngeal wall. These ICD-10-CM diagnosis codes are used to document primary hypopharyngeal cancers, specifying anatomic subsite and laterality when applicable to capture tumor location and extent. Accurate coding within the ICD-10-CM C13 group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Malignant Neoplasm Of Hypopharynx: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM C13: Malignant Neoplasm Of Hypopharynx Overview

    The ICD-10-CM C13 group represents malignant tumors originating in the hypopharynx, a region of the throat connecting the oropharynx to the esophagus. These diagnoses target cancers of the mucosal lining and adjacent structures of the hypopharynx and often affect swallowing and airway function. Accurate coding is important for correct clinical documentation and influences reimbursement and treatment planning.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use a code from this group when a patient has a confirmed primary malignant neoplasm of the hypopharynx documented by clinical evaluation, imaging, or pathology. Select the code that specifies the anatomic subsite and laterality as recorded in the medical record to accurately reflect the disease location and extent.

    ICD-10-CM Codes

    5 rows

    ICD-10-CM CodeDescription
    C13.0Malignant neoplasm of postcricoid region
    C13.1Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect
    C13.2Malignant neoplasm of posterior wall of hypopharynx
    C13.8Malignant neoplasm of overlapping sites of hypopharynx
    C13.9Malignant neoplasm of hypopharynx, unspecified

    DRG Codes

    6 rows

    DRG CodeDescription
    011Tracheostomy for Face, Mouth and Neck Diagnoses or Laryngectomy with MCC
    012Tracheostomy for Face, Mouth and Neck Diagnoses or Laryngectomy with CC
    013Tracheostomy for Face, Mouth and Neck Diagnoses or Laryngectomy without CC/MCC
    146Ear, Nose, Mouth and Throat Malignancy with MCC
    147Ear, Nose, Mouth and Throat Malignancy with CC
    148Ear, Nose, Mouth and Throat Malignancy without CC/MCC

    Typical Clinical Scenarios

    • A 62-year-old male with a long history of heavy tobacco and alcohol use presents with progressive dysphagia, odynophagia, and a painful mass felt in the posterior pharynx. Flexible laryngopharyngoscopy and biopsy confirm an invasive squamous cell carcinoma arising in the piriform sinus with local ulceration, and staging workup shows no distant metastasis; a malignant hypopharyngeal primary is documented, so a site-specific code is assigned. Typical codes: C13.0, C13.1
    • A 55-year-old female undergoing routine ENT follow-up for persistent hoarseness and globus sensation is found on exam to have a tumor centered in the postcricoid region with weight loss over months; biopsy demonstrates malignancy and treatment planning for combined surgery and radiotherapy is initiated. Because the cancer originates in a defined hypopharyngeal subsite and requires ongoing oncologic management, a hypopharyngeal neoplasm code from this group is used. Typical codes: C13.2, C13.8
    • A 68-year-old patient with a previously treated hypopharyngeal carcinoma presents acutely to the emergency department with profuse oropharyngeal bleeding and airway compromise from tumor erosion into surrounding vessels. Emergent hemorrhage control and airway stabilization are performed, and the visit is coded to reflect the active malignant hypopharyngeal lesion as the source of the complication. Typical codes: C13.8, C13.9

    Related Codes

    C00-MALIGNANT-NEOPLASM-OF-LIP

    ICD-10-CM Code For Malignant Neoplasm Of Lip: Group Overview

    C01-MALIGNANT-NEOPLASM-BASE-OF-TONGUE

    ICD-10-CM Code For Malignant Neoplasm Of Base Of Tongue: Group Overview

    C02-MALIGNANT-NEOPLASM-OF-TONGUE

    ICD-10-CM Code For Malignant Neoplasm Of Other And Unspecified Parts Of Tongue: Group Overview

    C03-MALIGNANT-NEOPLASM-OF-GUM

    ICD-10-CM Code For Malignant Neoplasm Of Gum: Group Overview

    C04-MALIGNANT-NEOPLASM-OF-FLOOR-OF-MOUTH

    ICD-10-CM Code For Malignant Neoplasm Of Floor Of Mouth: Group Overview

    C05-MALIGNANT-NEOPLASM-OF-PALATE

    ICD-10-CM Code For Malignant Neoplasm Of Palate: Group Overview

    C06-MALIGNANT-NEOPLASM-OF-MOUTH

    ICD-10-CM Code For Malignant Neoplasm Of Other And Unspecified Parts Of Mouth: Group Overview

    C07-MALIGNANT-NEOPLASM-OF-PAROTID-GLAND

    ICD-10-CM Code For Malignant Neoplasm Of Parotid Gland: Group Overview

    C08-MALIGNANT-SALIVARY-GLAND-NEOPLASMS

    ICD-10-CM Code For Malignant Neoplasm Of Other And Unspecified Major Salivary Glands: Group Overview

    C09-MALIGNANT-NEOPLASM-OF-TONSIL

    ICD-10-CM Code For Malignant Neoplasm Of Tonsil: Group Overview

    Showing 1–10 of 14

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.